Composition, form of production and packaging
Solution for inhalation 0.1% 1 ml
salbutamol hemisuccinate 1 mg
2.5 ml - bottles (10) - packs of cardboard.
5 ml - bottles (10) - packs cardboard.
10 ml - bottles (10) - packs of cardboard.
50 ml - bottles (1) - packs of cardboard.
INSTRUCTION FOR THE SPECIALIST.
The product description was approved by the manufacturer for the 2009 print edition.
The drug belongs to the group of selective agonists? 2- adrenergic receptors, interacting with? 2 -adrenoceptors of the bronchi.
Salgin relaxes the smooth musculature of the bronchi, inhibits the development of bronchospasm. Has little effect on the cardiovascular system. Virtually no adverse chronotropic effect.
- for relief of asthma attacks in bronchial asthma and for the prevention and treatment of reversible bronchial obstruction, including chronic obstructive bronchitis and other diseases of the respiratory system.
The solution is inhaled only through the nebulizer. The nebulizer turns the solution into an aerosol for inhalation. Before using the drug, you should carefully read the instructions for using the nebulizer:
1. Prepare the nebulizer for use.
2. Place the Salgim solution in a nebulizer.
Do not dilute the solution and / or mix with other drugs.
3. After the end of the inhalation, remove the remaining solution and wash the nebulizer.
When using Salgim through a nebulizer, the initial dose of the drug is 2.5 mg every 4-6 hours during the first 24-48 hours of therapy or until the clinical picture stabilizes. Improvement of the condition is observed after inhalation, usually after 10-15 minutes.
In severe exacerbation of chronic obstructive pulmonary disease, the frequency of Salgim administration can be significantly increased - it is possible to administer the drug every 30-60 minutes until the clinical effect is achieved.
Salgim can cause tremors in some patients, most often the hands. This effect is similar to that when using different dosage forms of salbutamol.
A number of patients may experience anxiety, nervous tension as a result of stimulation of skeletal muscle receptors.
There may be a decrease in blood pressure and a slight compensatory increase in heart rate. There may be a headache, hypokalemia and paradoxical bronchospasm.
- I and II trimester of pregnancy;
- combined use with beta-blockers, for example, with propranolol;
- signs of allergy to salbutamol or its derivatives.
It should be used with caution in patients suffering from thyrotoxicosis, diabetes mellitus, arrhythmias and during lactation.
PREGNANCY AND LACTATION
Contraindicated: I and II trimester of pregnancy.
Use with caution in lactation.
The drug is administered with caution to patients with tachyarrhythmia and other rhythm disturbances, myocarditis, heart defects (including aortic stenosis), arterial hypertension, acute heart failure, diabetes mellitus, thyrotoxicosis, glaucoma.
Symptoms: tachycardia, weakness, decreased blood pressure, muscle tremor.
Emergency assistance for overdose: symptomatic therapy, the introduction of cardioselective beta-blockers.
Salgim fits well with anti-asthmatic drugs of other pharmacotherapeutic groups (GCS, membrane stabilizers, antihistamines, expectorants, mucolytics, cholinoblockers, xanthines).
TERMS OF RELEASE FROM PHARMACY
The drug is released by prescription.
TERMS AND CONDITIONS OF STORAGE
List B. Store in a dark place at a temperature in the range of 5 to 25 В° C. The opened vial should not be stored for more than 24 hours in the refrigerator. Keep out of the reach of children.
Shelf life - 2 years. Do not use after the date indicated on the package.